Literature DB >> 2793860

Expression of human interleukin-2 in recombinant baby hamster kidney, Ltk-, and Chinese hamster ovary cells. Structure of O-linked carbohydrate chains and their location within the polypeptide.

H S Conradt1, M Nimtz, K E Dittmar, W Lindenmaier, J Hoppe, H Hauser.   

Abstract

The similarity or identity of O-glycosylation in glycoproteins from natural sources or produced in heterologous cell lines, a central problem for the development of many biotechnologically relevant production processes, was examined using interleukin-2 (IL-2) as a model. Human interleukin-2 was constitutively expressed in several mammalian cell lines in high amounts. The recombinant proteins were purified to homogeneity and their carbohydrate structures were analyzed. Only the NeuAc alpha 2-3Gal beta 1-3[NeuAc alpha 2-6]GalNAc oligosaccharide structure or the NeuAc alpha 2-3Gal beta 1-3GalNAc were found in all IL-2 preparations secreted from recombinant Ltk-, Chinese hamster ovary, and baby hamster kidney cell lines. The O-linked chains were exclusively linked to Thr in position 3 of the polypeptide chain which is the carbohydrate attachment site in natural human IL-2. The proportions of O-glycosylated versus nonglycosylated forms of the protein secreted by each recombinant cell line were independent of productivity or of cell culture conditions. Our results show that O-glycosylated human IL-2 can be produced by applying recombinant DNA technology in heterologous cell lines with the same type of post-translational modification that is observed for the protein secreted from natural T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2793860

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Insufficient (sub-native) helix content in soluble/solid aggregates of recombinant and engineered forms of IL-2 throws light on how aggregated IL-2 is biologically active.

Authors:  Uzma Fatima; Balvinder Singh; Karthikeyan Subramanian; Purnananda Guptasarma
Journal:  Protein J       Date:  2012-10       Impact factor: 2.371

Review 2.  Genetic engineering of recombinant glycoproteins and the glycosylation pathway in mammalian host cells.

Authors:  E Grabenhorst; P Schlenke; S Pohl; M Nimtz; H S Conradt
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

3.  Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: use of various cell lines.

Authors:  O W Merten; J V Kierulff; N Castignolles; P Perrin
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

4.  Expression of recombinant antibody and secreted alkaline phosphatase in mammalian cells. Influence of cell line and culture system upon production kinetics.

Authors:  A J Racher; J L Moreira; P M Alves; M Wirth; U H Weidle; H Hauser; M J Carrondo; J B Griffiths
Journal:  Appl Microbiol Biotechnol       Date:  1994-02       Impact factor: 4.813

5.  Cultural and physiological factors affecting expression of recombinant proteins.

Authors:  J B Griffiths; A J Racher
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

6.  Biochemical and immunological properties of rat recombinant interleukin-2 and interleukin-4.

Authors:  A J McKnight; B J Classon
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

Review 7.  Differentiating factors between erythropoiesis-stimulating agents: a guide to selection for anaemia of chronic kidney disease.

Authors:  Robert Deicher; Walter H Hörl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Site-specific detection and structural characterization of the glycosylation of human plasma proteins lecithin:cholesterol acyltransferase and apolipoprotein D using HPLC/electrospray mass spectrometry and sequential glycosidase digestion.

Authors:  P A Schindler; C A Settineri; X Collet; C J Fielding; A L Burlingame
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

9.  Human interleukin-2 (IL-2) expressed by transfected mammalian cells.

Authors:  M Knezević; K Vorauer-Uhl; O Hohenwarter; F Steindl; R Grabherr; P Raspor
Journal:  Pflugers Arch       Date:  1996       Impact factor: 3.657

10.  Characterization of bovine interleukin-2 stably expressed in HEK-293 cells.

Authors:  Shuya Mitoma; Heba M El-Khaiat; Tomofumi Uto; Katsuaki Sato; Satoshi Sekiguchi; Junzo Norimine
Journal:  J Vet Med Sci       Date:  2020-11-11       Impact factor: 1.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.